Do GLP-1 drugs cause cancer? New review says no, may even protect

A comprehensive analysis of clinical and preclinical data reveals that GLP-1 receptor agonists, previously suspected of increasing cancer risk, are generally safe and may even reduce the incidence of certain cancers through improved…

Continue Reading